• Ademetionine (S-Adenosylmethionine) in Methylation Workflows

  2026-06-19

  Leverage S-Adenosylmethionine (SAM) as a precision methyl donor for reproducible methylation reactions in CNS and epigenetic research. This guide details optimized protocols, advanced troubleshooting, and key insights from clinical translational studies, bridging molecular workflows with disease-relevant outcomes.

• (S)-(+)-Dimethindene maleate: M2 Antagonist Protocol & QC Gu

  2026-06-18

  (S)-(+)-Dimethindene maleate enables researchers to selectively antagonize M2 muscarinic and H1 histamine receptors in studies of autonomic regulation, cardiovascular physiology, and respiratory system function. It is not intended for diagnostic, therapeutic, or long-term storage applications, and should be used according to defined research protocols for reliable results.

• Ornithine–ZBTB7A Axis in Realgar-Induced CNS Toxicity: New M

  2026-06-18

  This study reveals how realgar, an arsenic-containing traditional medicine, induces central nervous system toxicity through hepatic ornithine accumulation and subsequent inhibition of astrocyte glycolysis via ZBTB7A regulation. The findings highlight the liver–brain metabolic interplay and identify new molecular targets for preventing arsenic-related neurotoxicity.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-17

  Anlotinib hydrochloride delivers superior, selective inhibition of key angiogenic pathways, empowering precise dissection of tumor microvascular dynamics. Bench-tested against leading TKIs, it offers enhanced workflow flexibility and reproducibility for advanced cancer research models.

• Imipenem in Antibacterial Research: Protocols, Pitfalls, and

  2026-06-17

  Imipenem, a semisynthetic thienamycin antibiotic, delivers robust broad-spectrum activity and unique immune-modulating effects, making it indispensable for antibacterial research and sepsis modeling. This article dissects evidence-based workflows and troubleshooting strategies, translating cutting-edge resistance epidemiology into practical laboratory guidance.

• Translating PTEN mRNA Science: Strategic Leaps for Cancer Re

  2026-06-16

  This article explores how advanced tumor suppressor gene mRNA tools, such as EZ Cap™ Human PTEN mRNA, are redefining translational cancer research. It integrates mechanistic insights from recent studies on hyaluronated lipid nanoparticles, highlights validated protocol strategies, and provides actionable guidance for researchers seeking to bridge lab innovation with clinical impact. The analysis differentiates itself from standard product pages by delivering a synthesis of workflow, evidence, and strategic foresight, with direct links to both the foundational science and real-world protocol resources.

• Scalable EPSC-iMSC EV Production: New Platform for Regenerat

  2026-06-16

  Gong et al. present a scalable, standardized platform for producing extracellular vesicles (EVs) from extended pluripotent stem cell-derived mesenchymal stem cells (EPSC-iMSCs), overcoming key challenges in donor variability and batch consistency. The system delivers high yields of therapeutically potent EVs, with demonstrated efficacy in a pulmonary fibrosis model, and sets a new benchmark for clinical translation of EV-based therapies.

• DAPI Solution (1 mg/mL): Precision DNA Staining in NP Cell S

  2026-06-15

  Explore the scientific underpinnings of DAPI Solution (1 mg/mL) for advanced nuclear visualization and viability assessment, with a focus on its role in studying nucleus pulposus cell senescence. This article goes beyond protocols, extracting practical insights from recent research and highlighting APExBIO’s unique offering.

• Cediranib (AZD2171) in Cancer Research: Applied Workflows &

  2026-06-15

  Cediranib (AZD2171) enables precise dissection of VEGFR-driven angiogenesis in advanced cancer models. This guide bridges robust stepwise workflows with troubleshooting insights and evidence-based assay optimization, empowering researchers to unlock new dimensions in tumor biology using APExBIO’s validated compound.

• Triterpene Prodrug Strategy for Targeted OSCC Chemotherapy

  2026-06-14

  This study introduces a carrier-free, self-assembled prodrug system based on triterpenes for the treatment of oral squamous cell carcinoma (OSCC). The research demonstrates a dual-responsive release mechanism and targeted delivery, advancing the design of effective, low-toxicity chemotherapeutics for OSCC.

• Dual-Action Inhibition Accelerates p38α MAPK Dephosphorylati

  2026-06-13

  The reference study demonstrates that certain kinase inhibitors not only block p38α MAP kinase activity but also accelerate its dephosphorylation by stabilizing a specific activation loop conformation. This dual-action mechanism offers a new strategy for increasing selectivity and efficacy in targeting MAP kinase pathways relevant to inflammation, cell death, and disease models.

• Tacalcitol Monohydrate: Synthetic Vitamin D3 Analog in Resea

  2026-06-12

  Tacalcitol monohydrate, a synthetic analog of vitamin D3, empowers researchers with highly reproducible workflows for dermatology and oncology applications, from NGF induction in keratinocytes to enhancing chemotherapeutic efficacy in colorectal cancer models. This guide unpacks advanced methods, troubleshooting tips, and actionable protocol parameters to maximize data quality and translational value.

• Dinaciclib (SCH727965): Enhancing Cell Cycle and Boundary As

  2026-06-12

  Dinaciclib (SCH727965) stands out as a multi-target CDK inhibitor, providing researchers with precise control over cell cycle arrest and apoptosis induction in cancer models. This guide translates the latest mechanobiology findings into actionable protocols, empowering cancer and developmental biology labs to interrogate tissue boundaries and cell proliferation with confidence.

• Resveratrol as a SIRT1 Activator: Precision Modulation in Ne

  2026-06-11

  Explore how resveratrol, a powerful SIRT1 activator, delivers precision neuroprotection by modulating apoptosis and mitochondrial biogenesis. This article offers a uniquely practical and mechanistic analysis for advanced assay design.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for Nanobiot

  2026-06-11

  Explore how Cy5-UTP (Cyanine 5-uridine triphosphate) advances RNA labeling for nanobiotechnology, bridging fluorescent probe synthesis with next-generation mRNA delivery assay design. Discover unique protocol insights and actionable guidance not found in standard overviews.

450 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page